Ismael Lopez
Physician Assistant · Harlingen, TXNPI 1235110495
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (34.8%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 33 manufacturers reported payments, led by Silk Road Medical, Inc. at 44.2% of the total. Reporting peaked in 2023 at $21,780 and has fallen 79.0% since, to $4,582 in 2025. Among physician assistant clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 405 payments — averaging $124.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Silk Road Medical, Inc.$22K
- Heartflow, Inc.$10K
- Biotronik Inc.$6K
- Medtronic$3K
- Abbott$2K
- Cvrx, Inc.$2K
- plus $6K from 27 others
What the payments were for
- Consulting fees$11,17822%
- Speaking & faculty fees$5,06310%
- Travel & lodging$17,56335%
- Food & beverage$16,63533%
- Education$340%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Silk Road Medical, Inc. | 68 | $22,290 |
| Heartflow, Inc. | 26 | $9,637 |
| Biotronik Inc. | 62 | $6,151 |
| Medtronic | 32 | $3,338 |
| Abbott | 36 | $1,807 |
| Cvrx, Inc. | 12 | $1,702 |
| E.r. Squibb & Sons, L.L.C. | 62 | $1,293 |
| Boston Scientific | 11 | $626 |
| Edwards Lifesciences | 4 | $432 |
| Boehringer Ingelheim | 8 | $327 |
| Abiomed | 4 | $294 |
| Chiesi USA, Inc. | 9 | $285 |
| Johnson & Johnson | 7 | $247 |
| Amgen | 13 | $226 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 6 | $220 |
| Bayer | 7 | $200 |
| AstraZeneca | 7 | $186 |
| Cardiovascular Systems Inc. | 3 | $160 |
| W. L. Gore & Associates, Inc. | 1 | $146 |
| Organogenesis Inc. | 2 | $126 |
| Shockwave Medical, Inc | 1 | $124 |
| Inspiremd Ltd | 1 | $112 |
| Actelion Pharmaceuticals US, Inc. | 1 | $98 |
| Pfizer | 6 | $91 |
| Sanofi-aventis U.S. LLC | 3 | $72 |
| Merck | 4 | $61 |
| Novo Nordisk | 3 | $58 |
| Cleerly, Inc. | 1 | $47 |
| Atricure, Inc. | 1 | $29 |
| Novartis | 1 | $25 |
| Tactile Systems Technology Inc | 1 | $23 |
| Lexicon Pharmaceuticals, Inc. | 1 | $21 |
| Esperion Therapeutics, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENROUTE Transcarotid Neuroprotection System$27,464
- ENROUTE Transcarotid Stent$21,079
- FFRct$9,281
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$6,523
- BioMonitor$3,521
- Solia$1,897
- Edora 8 DR-T$1,417
- Barostim Neo System$1,363
- Acticor 7 VR-T DX$1,311
- Rivacor 7 DR-T$1,311
- Rivacor$582
- Edora$582
- Acticor$582
- Micra$580
- JOT DX$266
- Sentus$206
- GORE EXCLUDER AAA Endoprosthesis$146
- SAPIEN 3 Ultra RESILIA$146
- AURORA EV-ICD MRI SURESCAN$137
- CLEVIPREX$128
How this compares
$50,473 in reported general payments places this provider in the 95th percentile of 8,308 physician assistant providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 184 | $232,859 |
| EntrestoSacubitril/Valsartan | 188 | $224,821 |
| XareltoRivaroxaban | 57 | $67,355 |
| Repatha SureclickEvolocumab | 20 | $19,973 |
| MultaqDronedarone Hcl | 11 | $18,584 |
| Clonidine | 41 | $7,044 |
| ClopidogrelClopidogrel Bisulfate | 178 | $2,336 |
| Ranolazine ErRanolazine | 25 | $2,235 |
| Metoprolol Succinate | 117 | $2,114 |
| Rosuvastatin Calcium | 176 | $1,739 |
| Metoprolol Tartrate | 258 | $1,423 |
| Losartan Potassium | 106 | $1,185 |
| Cilostazol | 47 | $1,158 |
| Amiodarone Hcl | 33 | $1,103 |
| Nitroglycerin | 90 | $1,029 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $91 | $232,859184 claims |
| NovartisEntresto | $25 | $224,821188 claims |
| Johnson & JohnsonXarelto | $247 | $67,35557 claims |
| Sanofi-aventis U.S. LLCMultaq | $72 | $18,58411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,308 physician assistant providers in Texas.
Other physician assistant in Harlingen
- Martha RodriguezHarlingen$35K
- Cynthia TrickettDallas$1.3M
- Kristine KuceraMelissa$797K
- Selina SantosAustin$543K
- Matthew BrunoMcKinney$538K
- Brooke HodnickSouthlake$479K
- Holly GloverArlington$418K
- Kirk GautierAthens$416K
- Jaime RomanPlano$338K
- Michael WhiteDallas$276K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.